Literature DB >> 12865761

Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans.

Mark O Goodarzi1, Xiuqing Guo, Kent D Taylor, Manuel J Quiñones, Carlos Samayoa, Huiying Yang, Mohammad F Saad, Aarno Palotie, Ronald M Krauss, Willa A Hsueh, Jerome I Rotter.   

Abstract

PURPOSE: To illustrate an approach of deriving haplotypes for genetic association studies, using the lipoprotein lipase (LPL) gene and coronary artery disease.
METHODS: Six polymorphisms sufficient to distinguish the most common haplotypes in the 3' end of LPL were identified by genotyping 10 polymorphisms in a small pilot population. These were used to haplotype LPL in large family samples of Mexican-Americans and non-Hispanic Caucasians. A case-control association study was performed comparing Mexican-Americans with and without coronary artery disease.
RESULTS: The two ethnic groups exhibited significant genetic differences. Among Mexican-Americans, homozygosity for LPL haplotype 1 was protective against coronary artery disease (OR = 0.50, 95% CI 0.27-0.91).
CONCLUSION: This study outlines the haplotype structure of the LPL gene, illustrates the utility of haplotype-based analysis in association studies, and demonstrates the importance of defining haplotype frequencies for different ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865761     DOI: 10.1097/01.GIM.0000076971.55421.AD

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  28 in total

1.  Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.

Authors:  Mark O Goodarzi; Heath J Antoine; Marita Pall; Jinrui Cui; Xiuqing Guo; Ricardo Azziz
Journal:  Fertil Steril       Date:  2007-01-30       Impact factor: 7.329

2.  Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Authors:  Xiaowen Su; Leland J Yee; KyungAh Im; Shannon L Rhodes; YongMing Tang; Xiaomei Tong; Charles Howell; Darmendra Ramcharran; Hugo R Rosen; Milton W Taylor; T Jake Liang; Huiying Yang
Journal:  J Hepatol       Date:  2008-05-20       Impact factor: 25.083

3.  Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance.

Authors:  Mark O Goodarzi; Jinrui Cui; Yii-Der I Chen; Willa A Hsueh; Xiuqing Guo; Jerome I Rotter
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-31       Impact factor: 4.310

4.  Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.

Authors:  Heath J Antoine; Marita Pall; Belynda C Trader; Yii-Der I Chen; Ricardo Azziz; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2006-12-04       Impact factor: 7.329

5.  CRTC3 links catecholamine signalling to energy balance.

Authors:  Youngsup Song; Judith Altarejos; Mark O Goodarzi; Hiroshi Inoue; Xiuqing Guo; Rebecca Berdeaux; Jeong-Ho Kim; Jason Goode; Motoyuki Igata; Jose C Paz; Meghan F Hogan; Pankaj K Singh; Naomi Goebel; Lili Vera; Nina Miller; Jinrui Cui; Michelle R Jones; Yii-Der I Chen; Kent D Taylor; Willa A Hsueh; Jerome I Rotter; Marc Montminy
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

6.  Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.

Authors:  Angela K Chua; Ricardo Azziz; Mark O Goodarzi
Journal:  Mol Hum Reprod       Date:  2012-01-10       Impact factor: 4.025

7.  Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome.

Authors:  M O Goodarzi; N Xu; J Cui; X Guo; Y I Chen; R Azziz
Journal:  Hum Reprod       Date:  2008-03-10       Impact factor: 6.918

8.  A Multinomial Ordinal Probit Model with Singular Value Decomposition Method for a Multinomial Trait.

Authors:  Soonil Kwon; Mark O Goodarzi; Kent D Taylor; Jinrui Cui; Y-D Ida Chen; Jerome I Rotter; Willa Hsueh; Xiuqing Guo
Journal:  J Probab Stat       Date:  2012-03-31

9.  Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.

Authors:  Ning Xu; Kent D Taylor; Ricardo Azziz; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2009-03-26       Impact factor: 7.329

10.  Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.

Authors:  Mark O Goodarzi; Michelle R Jones; Heath J Antoine; Marita Pall; Yii-Der I Chen; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.